Sartorius Stedim [DIM] vs Visiomed Group SA [ALVMG] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sartorius Stedim wins in 11 metrics, Visiomed Group SA wins in 7 metrics, with 0 ties. Sartorius Stedim appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSartorius StedimVisiomed Group SABetter
P/E Ratio (TTM)76.8457.80Visiomed Group SA
Price-to-Book Ratio4.402.10Visiomed Group SA
Debt-to-Equity Ratio73.5132.03Visiomed Group SA
PEG Ratio2.025.75Sartorius Stedim
EV/EBITDA28.6529.71Sartorius Stedim
Profit Margin (TTM)7.78%6.58%Sartorius Stedim
Operating Margin (TTM)17.32%6.76%Sartorius Stedim
EBITDA Margin (TTM)17.32%6.76%Sartorius Stedim
Return on Equity5.69%3.68%Sartorius Stedim
Return on Assets (TTM)3.44%0.68%Sartorius Stedim
Free Cash Flow (TTM)$475.30M$-1.50MSartorius Stedim
Dividend Yield0.35%N/AN/A
1-Year Return-0.65%23.53%Visiomed Group SA
Price-to-Sales Ratio (TTM)5.963.88Visiomed Group SA
Enterprise Value$19.91B$56.21MSartorius Stedim
EV/Revenue Ratio6.884.10Visiomed Group SA
Gross Profit Margin (TTM)46.27%N/AN/A
Revenue per Share (TTM)$30$0Sartorius Stedim
Earnings per Share (Diluted)$2.31$0.00Sartorius Stedim
Beta (Stock Volatility)0.93-0.63Visiomed Group SA
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Sartorius Stedim vs Visiomed Group SA Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sartorius Stedim0.88%-0.40%-7.43%-11.07%-13.75%-4.75%
Visiomed Group SA1.45%5.00%16.67%16.67%0.00%23.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sartorius Stedim-0.65%-53.41%-40.52%270.30%1,775.53%1,775.53%
Visiomed Group SA23.53%-48.78%-80.19%-89.12%-92.98%-92.98%

Performance & Financial Health Analysis: Sartorius Stedim vs Visiomed Group SA

MetricDIMALVMG
Market Information
Market Cap i€17.27B€53.17M
Market Cap CategoryLarge capSmall cap
10 Day Avg. Volume i60,426500,329
90 Day Avg. Volume i75,836543,191
Last Close€177.85€0.21
52 Week Range€148.75 - €239.80€0.15 - €0.25
% from 52W High-25.83%-17.49%
All-Time High€551.00 (Sep 06, 2021)€173.86 (Dec 15, 2014)
% from All-Time High-67.72%-99.88%
Growth Metrics
Quarterly Revenue Growth0.06%0.29%
Quarterly Earnings Growth0.44%N/A
Financial Health
Profit Margin (TTM) i0.08%0.07%
Operating Margin (TTM) i0.17%0.07%
Return on Equity (TTM) i0.06%0.04%
Debt to Equity (MRQ) i73.5132.03
Cash & Liquidity
Book Value per Share (MRQ)€40.33€0.08
Cash per Share (MRQ)€7.08€0.01
Operating Cash Flow (TTM) i€788.10M€1.11M
Levered Free Cash Flow (TTM) i€444.60M€-488,000
Dividends
Last 12-Month Dividend Yield i0.35%N/A
Last 12-Month Dividend i€0.69N/A

Valuation & Enterprise Metrics Analysis: Sartorius Stedim vs Visiomed Group SA

MetricDIMALVMG
Price Ratios
P/E Ratio (TTM) i76.8457.80
Forward P/E i41.185.75
PEG Ratio i2.025.75
Price to Sales (TTM) i5.963.88
Price to Book (MRQ) i4.402.10
Market Capitalization
Market Capitalization i€17.27B€53.17M
Enterprise Value i€19.91B€56.21M
Enterprise Value Metrics
Enterprise to Revenue i6.884.10
Enterprise to EBITDA i28.6529.71
Risk & Other Metrics
Beta i0.93-0.63
Book Value per Share (MRQ) i€40.33€0.08

Financial Statements Comparison: Sartorius Stedim vs Visiomed Group SA

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DIMALVMG
Revenue/Sales i€744.60MN/A
Cost of Goods Sold i€388.30MN/A
Gross Profit i€356.30MN/A
Research & Development i€39.20MN/A
Operating Income (EBIT) i€141.30MN/A
EBITDA i€256.10MN/A
Pre-Tax Income i€115.40MN/A
Income Tax i€30.00MN/A
Net Income (Profit) i€85.40MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DIMALVMG
Cash & Equivalents i€707.60M€2.97M
Total Current Assets i€1.78B€5.28M
Total Current Liabilities i€964.70M€3.38M
Long-Term Debt i€2.84B€7.64M
Total Shareholders Equity i€4.01B€24.75M
Retained Earnings i€2.53B€902,000
Property, Plant & Equipment iN/A€7.30M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DIMALVMG
Operating Cash Flow i€111.30MN/A
Capital Expenditures iN/AN/A
Free Cash Flow i€54.50MN/A
Debt Repayment i€-13.70MN/A
Common Stock Repurchase i€-2.00MN/A

Short Interest & Institutional Ownership Analysis

MetricDIMALVMG
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i60,426500,329
Average Daily Volume (90 Day) i75,836543,191
Shares Outstanding i97.30M294.17M
Float Shares i28.30MN/A
% Held by Insiders i0.71%0.00%
% Held by Institutions i0.11%0.02%

Dividend Analysis & Yield Comparison: Sartorius Stedim vs Visiomed Group SA

MetricDIMALVMG
Last 12-Month Dividend i€0.69N/A
Last 12-Month Dividend Yield i0.35%N/A
3-Year Avg Annual Dividend i€0.94N/A
3-Year Avg Dividend Yield i0.40%N/A
3-Year Total Dividends i€2.82N/A
Ex-Dividend DateApr 02, 2025N/A